| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing pentastarch (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentastarch (substance) |
Inferred relationship |
Some |
1 |
| Pentastarch adverse reaction |
Causative agent (attribute) |
True |
Pentastarch (substance) |
Inferred relationship |
Some |
1 |
| Pentastarch allergy |
Causative agent (attribute) |
False |
Pentastarch (substance) |
Inferred relationship |
Some |
|
| Pentastarch 10% infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentastarch (substance) |
Inferred relationship |
Some |
|
| Pentastarch 6% infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentastarch (substance) |
Inferred relationship |
Some |
|
| Pentastarch 10g/100mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentastarch (substance) |
Inferred relationship |
Some |
|
| Pentastarch 10% injection solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentastarch (substance) |
Inferred relationship |
Some |
|
| Pentastarch 10g/100mL intravenous solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentastarch (substance) |
Inferred relationship |
Some |
|
| Pentastarch 6% in sodium chloride 7.2% intravenous infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentastarch (substance) |
Inferred relationship |
Some |
|
| Infusion of pentastarch (procedure) |
Direct substance |
False |
Pentastarch (substance) |
Inferred relationship |
Some |
1 |
| Infusion of pentastarch (procedure) |
Direct substance |
True |
Pentastarch (substance) |
Inferred relationship |
Some |
1 |
| Non-allergic hypersensitivity to pentastarch |
Causative agent (attribute) |
False |
Pentastarch (substance) |
Inferred relationship |
Some |
|
| Non-allergic hypersensitivity to pentastarch |
Causative agent (attribute) |
True |
Pentastarch (substance) |
Inferred relationship |
Some |
1 |
| Pentastarch 10g/100mL conventional release solution for infusion 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentastarch (substance) |
Inferred relationship |
Some |
|
| Pentastarch 6% in sodium chloride 7.2% conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentastarch (substance) |
Inferred relationship |
Some |
|
| Product containing only pentastarch (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentastarch (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely pentastarch 60 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pentastarch (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely pentastarch 60 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pentastarch (substance) |
Inferred relationship |
Some |
1 |
| Pentastarch 100 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pentastarch (substance) |
Inferred relationship |
Some |
1 |
| Pentastarch 100 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pentastarch (substance) |
Inferred relationship |
Some |
1 |
| Pentastarch-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentastarch (substance) |
Inferred relationship |
Some |
1 |
| Product containing only pentastarch in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentastarch (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]